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Pulmonary arteriovenous malformations (PAVMs), although most commonly congenital, are usually detected later in life. We
present a case of a 25-year-old woman with no previous history of AVM or telangiectasia, who presented with life-threatening
hypoxia, hypotension, and pleuritic chest pain in 36th week of gestation. Chest tube placement revealed 4 liters of blood. Patient
was subsequently found to have bleeding pulmonary AVM as the source of hemothorax. Successful embolisation of the bleeding
vessel followed by thoracoscopic evacuation of the organized clot relieved the hypoxia. Further screening for AVM revealed large
splenic AVM for which patient underwent splenectomy in the coming months.
1.CasePresentation
Our patient was a 25-year-old previously healthy female
at 36th week gestation presented to the hospital with 4
days of progressive dyspnea and right-sided pleuritic chest
pain. Her past medical history was pertinent for gestational
thrombocytopenia which resolved spontaneously but no
history of epistaxis or family history of Osler-Weber-Rendu
syndrome was noted. She was found to be hypotensive and
hypoxic on ventilator support. Chest X-ray revealed right-
sided pleural eﬀusion which caused complete hemithorax
opaciﬁcation.
Patient underwent emergent cesarean delivery due to
unstable vital signs and frequent fetal decelerations. Due to
persistent hypoxia and hypotension, patient was admitted to
ICU with ventilator support. Physical exam was signiﬁcant
fordecreasedbreathsoundsontherightside,dullpercussion
note, and decreased vocal tactile fremitus but no evidence of
cyanosis.
Vital signs were systolic blood pressure of 80mmHg,
diastolic blood pressure of 40mmHg, pulse rate 142/min,
pulse oximetry saturation 86% to 88% on 100% inspired
oxygen, afebrile, and respiratory rate of 30/min. Patient
was visibly diaphoretic using accessory muscles with sinus
tachycardia noted on monitor.
Initial labs revealed normal platelets, normal coagulation
panel, and hemoglobin of 6.5gm/dL. Critical care panel
showed pH of 7.4, pCO2 of 50mmhg, pAO2 60mmhg, and
saturation of 88%.
A chest tube was placed which revealed a hemothorax.
fourliters of frank blood was removed with the chest tube
placement which also resulted in normalization of the blood
pressure and improved oxygenation on the monitor. Repeat
chestX-rayshowed continuedopaciﬁcationoftherightlung,
and the patient’s hemoglobin continued to fall (Figure 1).
CT-chest with IV contrast showed a likely 1cm area of active
contrast extravasation along with compressive atelectasis of
the right lower lobe.
Pulmonary angiography conﬁrmed an AVM with feed-
ing branch of a basilar right pulmonary artery supplying
aneurysmal AVM and dilated draining vein. Embolisation of
the culprit vessel was performed (Figure 3).2 Pulmonary Medicine
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Figure 1: Chest X-ray showing right hemithorax opaciﬁcation.
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Figure 2: Computed tomography of the chest with I.V. contrast
showingright-sided pleural eﬀusion.
Figure 3: Interventional radiologist-guided embolisation of the
right pulmonary artery which wasthe culprit vessel.
RepeatchestX-rayshowedcontinuedopaciﬁcationofthe
right lung and suspecting an organized blood clot thoraco-
scopic evacuation was performed.
2.Results
Patient had an uncomplicated course subsequently and was
discharged home after 4 days. Evaluation for AVM with a
head MRI was negative. CT scan of the abdomen revealed
splenomegaly with a large 11cm × 9cm × 6cm splenic
mass. Patient then underwent splenectomy, where the ﬁnal
pathology report showed the splenic mass consistent with
AVM. Examination or genetic testing for hereditary hemor-
rhagic telangiectasia (HHT) was not performed during this
hospitalization.
3.Discussion
Pulmonary AVMs are abnormal vascular structures that
provide a direct capillary-free communication between the
pulmonary and systemic circulation which causes right-to-
left shunt, hypoxia, and increases the risk of paradoxical
emboli including cerebral abscess [1, 2].
T h e s eA V M si n c r e a s ei ns i z ed u r i n gp r e g n a n c y[ 3].
PAVMs occur most commonly in individuals aﬀected
by the inherited vascular disorder HHT, or Osler-Weber-
Rendu syndrome [4, 5]. In a series of 219 consecutive PAVM
patients, a clinical diagnosis of HHT could be established
in 93.6% of cases [2]. Criteria for hereditary hemorrhagic
telangiectasia include spontaneous recurrent nosebleeds,
mucocutaneous telangiectasia, visceral involvement, and an
aﬀected ﬁrst-degree relative [5]. It is important for families
(and medical practitioners) to be aware that no child of
a patient with HHT can be informed that he or she does
not have HHT unless a genetic test has been performed
for a disease causing mutation, as such a mutation can be
identiﬁed in 85% of HHT patients [6].
It is important to evaluate all patients with PAVM for
signs of HHT. This involves meticulous exam for telang-
iectatic lesions by looking in the oral cavity, the lips, and
nasal mucosausing rigidrhinoscopy. Theskin ofthefaceand
ﬁngertips and look in the conjunctive of the eye should be
included.
Criteria for screening for AVM include patients with
HHT patients with cerebral abscesses and any young patient
with an embolic cerebrovascular accidentevenifan apparent
alternative cause is present [7].
Screening for pulmonary AVM includes chest radio-
graph, arterial blood gas on oxygen, and bubble contrast
echocardiogram to evaluate for pulmonary shunting [8].
Screening for cerebral AVM includes MRI and MR angiog-
raphy (MRA) of the brain although cerebral angiography
is most sensitive. Computed tomography of the abdomen
and pelvis is recommended for screening for AVM in the
abdomen (Figure 2)[ 8].
Repeat screening procedures every 5 years or at times
when the number and size of AVM increase such as during
puberty or pregnancy [9].Pulmonary Medicine 3
Pregnancies should be managed with close liaison
between obstetricians, pulmonologists, and interventional
radiologists,usingappropriate“high-risk”obstetricmanage-
ment strategies [9]. To reduce risk of brain abscess in cases
of undiagnosed pulmonary AVM, antibiotic prophylaxis is
recommended prior to dental procedures[10]. Embolisation
remains the treatment ofchoice as demonstrated by multiple
studies [11].
4.Conclusion
Previously, several cases of pulmonary AVM have been
described in the literature with a large proportion of cases
associated with hereditary telangiectasia.
Our patient’s presentation with life-threatening ﬁndings
in pregnancy with no previously signiﬁcant medical history
is unique. These AVM expand during pregnancy because of
increases in blood volume, cardiac output, and venous dis-
tensibility [3]. Presence of AVM should be considered in the
settingofpregnancy,hypoxia,andspontaneoushemothorax.
Further screening for other sites of AVM should be discussed
and pursued. Women with known pulmonary AVM should
be maximally treated prior to becoming pregnant, and the
physician should be alert to complications of pulmonary
AVM during pregnancy. This case emphasizes the impor-
tance of thinking beyond the current event of hemothorax
which resulted in ﬁnding of large splenic AVM in timely
manner, and subsequent treatment preventedcomplications.
Examination or genetic testing for hereditary hemorrhagic
telangiectasia (HHT) was regrettably not performed.
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